Herbalife Ltd. announced its financial results for the first quarter of 2025. Net sales during the quarter reached $1.2 billion, a 3.4% year-over-year decrease, with a net income of $50.4 million. Adjusted EBITDA exceeded guidance at $164.9 million with an adjusted diluted EPS of $0.59.
Gross profit margin in the quarter improved slightly to 78.3%. Net cash provided by operating activities fared better than expected and reached $0.2 million. The company cited the first quarter as one that tends to be “the lowest cash flower quarter of the year” because of distributor and employee performance bonuses. Even so, this is the fourth consecutive quarter of year-over-year growth for new distributor numbers worldwide, which the company believes signals strong global engagement and positive momentum.
“Our first quarter results were strong, and we raised our full-year 2025 Adjusted EBITDA expectations,” said Stephan Gratziani, Herbalife President and incoming CEO. “Our recent acquisitions strengthen our position and support our commitment to transformative growth.”
The company’s recent asset acquisition of Pro2col LLC and Pruvit as well as gaining a 51% ownership interest in Texas-based manufacturing company HBL Link Bioscience LLC, required an investment of $25.5 million, but is expected to create unique opportunities to expand customer reach through a personalized health, wellness and nutrition platform. Blake Mallen, previously Pruvit President, will now serve as Herbalife Chief Strategy Officer and Pro2col President.
“As I transition into the role of CEO, I am committed to honoring Herbalife’s 45-year legacy of empowering our communities through health, wellness and a strong entrepreneurial opportunity,” Gratziani said. “Our recent acquisitions are a bold step to provide innovation and growth as we move toward our vision of becoming the world’s premier health and wellness company, community and platform.”
